This inventor holds 6 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, Fondation Imagine - Institut Des Maladies Genetiques, National Institute of Health and Medical Research. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 331 
4 out of 4 
4 out of 1,853 
Years Active: 2022-2026
Title: Exploring the Innovations of Inventor Marina Cavazzana
Introduction
Marina Cavazzana is a distinguished inventor based in Paris, France, known for her significant contributions to the field of cell therapy. With a total of four patents to her name, her work primarily focuses on developing methods to generate T-cell progenitors, which hold immense potential in therapeutic applications.
Latest Patents
Among Marina's most notable inventions are her latest patents which detail innovative methods for generating T-cell progenitors. The first patent outlines an in vitro method in which CD34+ cells are exposed to a medium containing a Notch ligand, specifically a soluble domain of the Delta-like ligand 4, combined with an Fc region of a protein IgG. This method is further enhanced by the inclusion of a fibronectin fragment that contains crucial motifs such as RGDS and CS-1, alongside a heparin-binding domain.
The second patent presents a unique approach to cultivating CD34+ cells in the presence of TNF-alpha and/or an antagonist of the Aryl hydro-carbon/Dioxin receptor, notably StemRegenin 1 (SR1). This innovative technique also incorporates a Notch ligand and, optionally, a fibronectin fragment to effectively generate T-cell progenitors.
Career Highlights
Throughout her career, Marina Cavazzana has made her mark in renowned organizations. She has worked with Assistance Publique-Hôpitaux de Paris and the Institut National de la Santé et de la Recherche Médicale, where she has been integral in advancing research in medical science.
Collaborations
Marina has collaborated with several esteemed colleagues, including Isabelle André and Kuiying Ma, whose partnerships have further propelled her research endeavors. These collaborations exemplify the interdisciplinary approach essential in the field of innovative medical technologies.
Conclusion
In summary, Marina Cavazzana stands out as a vital contributor to the field of cell therapy through her innovative methods for generating T-cell progenitors. Her patents and professional collaborations reflect her commitment to advancing scientific knowledge and improving therapeutic options in the realm of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile